Zdrowie i gospodarka · 12/06/2012
FDA Releases Draft Guidance on Transferring Clinical Investigation Oversight
The FDA has released a draft guidance document outlining considerations for transferring clinical investigation oversight from one Institutional Review Board (IRB) to another, addressing regulatory responsibilities and procedures for clinical investigators and sponsors.